Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.

Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, DiPatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, MacDonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW.

Neuro Oncol. 2018 Oct 9;20(11):1547-1555. doi: 10.1093/neuonc/noy070.

2.

Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy.

Aguilera D, Castellino RC, Janss A, Schniederjan M, McNall R, MacDonald T, Mazewski C.

Childs Nerv Syst. 2018 Feb;34(2):329-334. doi: 10.1007/s00381-017-3584-x. Epub 2017 Sep 30.

PMID:
28965234
3.

Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib.

Aguilera D, Janss A, Mazewski C, Castellino RC, Schniederjan M, Hayes L, Brahma B, Fogelgren L, MacDonald TJ.

Pediatr Blood Cancer. 2016 Mar;63(3):541-3. doi: 10.1002/pbc.25787. Epub 2015 Nov 18.

PMID:
26579623
4.

The rationale for targeted therapies in medulloblastoma.

MacDonald TJ, Aguilera D, Castellino RC.

Neuro Oncol. 2014 Jan;16(1):9-20. doi: 10.1093/neuonc/not147. Epub 2013 Dec 4. Review.

5.

Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.

Aguilera D, Flamini R, Mazewski C, Schniederjan M, Hayes L, Boydston W, Castellino RC, MacDonald TJ.

J Pediatr Hematol Oncol. 2014 Oct;36(7):e448-51. doi: 10.1097/MPH.0000000000000005.

6.

Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience.

Aguilera D, Mazewski C, Fangusaro J, MacDonald TJ, McNall-Knapp RY, Hayes LL, Kim S, Castellino RC.

Childs Nerv Syst. 2013 Apr;29(4):589-96. doi: 10.1007/s00381-012-2013-4. Epub 2013 Jan 8.

7.

Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.

Aguilera DG, Mazewski C, Hayes L, Jordan C, Esiashivilli N, Janns A, Macdonald TJ.

J Pediatr Hematol Oncol. 2013 Jan;35(1):e42-6. doi: 10.1097/MPH.0b013e318279aed8.

PMID:
23249962
8.

Drop metastases to the pediatric spine revealed with diffusion-weighted MR imaging.

Hayes LL, Jones RA, Palasis S, Aguilera D, Porter DA.

Pediatr Radiol. 2012 Aug;42(8):1009-13. doi: 10.1007/s00247-011-2295-9. Epub 2011 Nov 4.

PMID:
22052343
9.

Incidental resolution of a radiation-induced cavernous hemangioma of the brain following the use of bevacizumab in a child with recurrent medulloblastoma.

Aguilera D, Tomita T, Goldman S, Fangusaro J.

Pediatr Neurosurg. 2010;46(4):303-7. doi: 10.1159/000321801. Epub 2010 Dec 30.

PMID:
21196797
10.

Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature.

Aguilera DG, Mazewski C, Schniederjan MJ, Leong T, Boydston W, Macdonald TJ.

Childs Nerv Syst. 2011 May;27(5):757-64. doi: 10.1007/s00381-010-1351-3. Epub 2010 Dec 4. Review.

PMID:
21132433
11.

Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma.

Aguilera DG, Goldman S, Fangusaro J.

Pediatr Blood Cancer. 2011 Mar;56(3):491-4. doi: 10.1002/pbc.22868.

PMID:
21072819
12.

Evaluating the incidence and utility of microscopic metastatic dissemination as diagnosed by lumbar cerebro-spinal fluid (CSF) samples in children with newly diagnosed intracranial ependymoma.

Fangusaro J, Van Den Berghe C, Tomita T, Rajaram V, Aguilera D, Wang D, Goldman S.

J Neurooncol. 2011 Jul;103(3):693-8. doi: 10.1007/s11060-010-0448-6. Epub 2010 Nov 1.

PMID:
21038109
13.

Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines.

Das CM, Zage PE, Taylor P, Aguilera D, Wolff JE, Lee D, Gopalakrishnan V.

Eur J Cancer. 2010 Oct;46(15):2771-80. doi: 10.1016/j.ejca.2010.05.010.

14.

Glioblastoma multiforme in a patient with chronic granulomatous disease treated with subtotal resection, radiation, and thalidomide: case report of a long-term survivor.

Aguilera DG, Tomita T, Rajaram V, Fangusaro J, Katz BZ, Shulman S, Goldman S.

J Pediatr Hematol Oncol. 2009 Dec;31(12):965-9. doi: 10.1097/MPH.0b013e3181b84751.

PMID:
19887959
15.

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.

Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ.

J Pediatr Hematol Oncol. 2009 Nov;31(11):803-11. doi: 10.1097/MPH.0b013e3181ba43dc.

PMID:
19801947
16.

Dasatinib in chronic myeloid leukemia: a review.

Aguilera DG, Tsimberidou AM.

Ther Clin Risk Manag. 2009 Apr;5(2):281-9. Epub 2009 May 4.

17.

Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.

Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V.

J Neurooncol. 2009 Jul;93(3):303-18. doi: 10.1007/s11060-008-9788-x. Epub 2009 Jan 16.

18.

Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor.

Aguilera D, Hayes-Jordan A, Anderson P, Woo S, Pearson M, Green H.

Sarcoma. 2008;2008:261589. doi: 10.1155/2008/261589.

19.

Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.

Anderson P, Aguilera D, Pearson M, Woo S.

Cancer Control. 2008 Jan;15(1):38-46. Review.

PMID:
18094659
20.

Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.

Das CM, Aguilera D, Vasquez H, Prasad P, Zhang M, Wolff JE, Gopalakrishnan V.

J Neurooncol. 2007 Nov;85(2):159-70. Epub 2007 May 30.

PMID:
17534580

Supplemental Content

Loading ...
Support Center